Literature DB >> 25161689

The association of genetic variations with sensitivity of blood pressure to dietary salt: A narrative literature review.

Saeid Doaei1, Maryam Gholamalizadeh2.   

Abstract

Salt sensitivity of blood pressure (BP) is an independent risk factor for cardiovascular morbidity. Up to 50% of patients with essential hypertension are salt-sensitive, as manifested by a rise in BP with salt intake. Several genetic variations have been identified as being associated with salt sensitivity. The present study aimed to review the evidence on the effect of gene polymorphisms on the salt sensitivity of BP. We searched in PubMed website from 1990 to 2011, with the use of following keywords: "hypertension, dietary salt, polymorphisms, and blood pressure". The effect of sodium intake on BP differed by genotype at the genes of the renin-angiotensin system, aldosterone synthase, cytochrome p450 3A, epithelial sodium channel genes, genes of sympathetic nervous system, β-3 subunit of G-protein, alpha-adducin, endothelial nitric oxide synthase, Kallikrein-Kinin system. These approaches suggest that these polymorphisms may be potentially useful genetic markers of BP response to dietary salt. There is evidence that genetic predisposition modulates the BP response to diet. Therefore, diet and nutrition can mitigate or enhance the effects of genetic predisposition. Increasing our knowledge of this relationship can lead to individualized treatment and increased understanding of hypertension.

Entities:  

Keywords:  Diet Therapy; Genetics; Hypertension

Year:  2014        PMID: 25161689      PMCID: PMC4144382     

Source DB:  PubMed          Journal:  ARYA Atheroscler        ISSN: 1735-3955


Introduction

Hypertension is a major worldwide risk factor for cardiovascular diseases (CVDs) such as heart attack, congestion, heart failure, stroke, and peripheral vascular disease.1 The prevalence of hypertension has dramatically increased in recent years.2 Essential hypertension is a complex disease that characterized by chronically elevation in blood pressure (BP) with no specific underlying medical or biological cause.3 As that shown in the previous studies in the field of similar problems such as hyperlipidemia and other CVDs,4 hypertension is a complex trait resulting from interaction of multiple genetic factors and lifestyle exposures including: dietary salt intake, alcohol consumption, and body weight.5 The heritability of hypertension is often reported in the range of 30-60%.6 Requirements and tolerable upper limits of nutrients could be different in different people.7 Several studies of nutritional genomics have shown that some of the gene variations could influence the level of nutrients requirements.8 On the other hand, intake of some nutrients could alter the gene expression and protein synthesis.9 High dietary sodium intake is the most prevalent risk factor in modern societies. Although many studies found that high dietary salt intake is associated with hypertension, but BP responses to high and low salt intake may be influenced by various genetic factors10 and some studies have suggested that dietary sodium restriction may not be beneficial to everyone. Salt restriction has been reported to decrease cognitive function in salt sensitive and salt resistant population;11 thus, there is a need to recognize the genetics determinants of salt sensitivity that increase our understanding of the mechanism underlying hypertension and finally distinguish salt sensitive from salt resistant subjects. Salt sensitivity of BP is defined by the observed changes of arterial pressure as daily salt intake is changed.12 Most studies searching for genetics causes of essential hypertension have been observed association between candidate genes with salt sensitive hypertension. These genes including: renin-angiotensin converting enzyme (ACE) gene, angiotensinogen (AGT) gene, angiotensin II type 1 receptor, epithelial sodium channel (ENaC) genes, 11-beta hydroxy steroid dehydrogenase (11-BHSD) genes, sympathetic alpha receptor gene, beta receptor gene, endothelial nitric oxide synthase gene, adducin gene, and others.13 This narrative literature review outlines some of genes associated with salt sensitive hypertension; emphases on genetic variations related to salt sensitivity in individuals and highlight the recent finding on the genetic basis of salt sensitive hypertension.

Genes of Renin-Angiotensin System (RAS)

The renin-angiotensin system (RAS) is the most important regulation of homeostatic system that controls body fluid volume, electrolyte balance, and BP.14 Components of RAS were studied as candidate genes for salt sensitive hypertension. The most studies have examined several loci within this system: the ACE gene, the AGT gene, and the angiotensin type 1 receptor gene.

ACE Gene

Many studies have examined the association between ACE and salt sensitivity.15-17Meneton et al. found that the prevalence of salt sensitivity hypertension in II phenotype and ID phenotype is significantly higher than DD phenotype.15 Zhang et al. found that ACE I/D had been significant association with salt sensitivity hypertension.17 However, reports of the association between ACE genotype and salt sensitivity hypertension were inconsistent. Strazzullo et al. in a meta-analysis of 145 case-control studies observed that DD homozygote and ID heterozygote had increased CVD, but not for hypertension in contrast with II homozygote.18

AGT Gene

Norat et al. found that molecular variants in the AGT gene including M235T, T174M, and mutation in the promoter region that involve in the insertion of adenine instead of guanine (G-6A) had been a positive association with salt sensitivity hypertension19 that was in line with results of two previous studies.20,21 Schorr et al. found that the presence of the AA (or TT) genotype in the promoter region is associated with salt-sensitive BP.21 Also, Hunt et al. found an association between AGT-GG linkages with AGT M235T with a decrease in BP after a decrease in sodium intake.22 Beeks et al. concluded that patients who are homozygous for M allele had lower BP after mild salt restriction compare with TT and MT genotype.23 Svetkey et al. found that BP response to the dietary approaches to stop hypertension (DASH) diet is higher in the genotype of G-6A AGT SNP than GG genotype.24

Angiotensin Type 1 Receptor

Anginotensin II regulates vascular contracting, BP and sodium reabsorbing by kidney through binding with angiotensin II receptor.25 Two subtype of gene variations of angiotensin II type 1 receptor, 1A (AT1AR) and 1B (AT1BR), may effect on BP.26 Moreover, Gu et al. found an association between rs4524238 alleles G/A and A/A with salt sensitivity hypertension.27

Aldestron Synthase

Aldestron secretes by the adrenal gland and has been important in the regulation of water electrolyte balance.28 This hormone synthesize by the aldosterone synthase enzyme, which is encoded by the CYP11B2 gene.29 Many studies reported that CYP11B2 polymorphisms, especially −344C/T are associated with salt sensitivity hypertension.30-32 However, in two studies CYP11B2 T344C polymorphism was not associated with hypertension.18,23

11ΒHSD2 Gene

Mineralocorticoid activity may be increased with decreased activity of 11BHSD2, which inactivates 11-hydroxy steroids in the kidney, thereby protecting the nonselective mineralocorticoid receptor from occupation by glucocorticoids.33 Smolenicka et al. found that Mutations in the 11ΒHSD2 gene may lead to a rare form of salt sensitive hypertension.34 Alikhani-Koupaei et al. identified polymorphism G534A in exon 3 of this gene could increase susceptibility to salt sensitive hypertension.35

Cytochrome p450 3A (Cyp3A)

Cytochrome p450 3A (Cyp3A) is a subfamily of cytochrome P (CYP) 450. This group of cytochromes are involved in the metabolism of drugs (e.g., anti-hypertensive drugs) and endogenous substrate such as steroids. These metabolites effect on renal sodium transport.36 Components of Cyp3A subfamily are located on chromosome 7q22. These genes include Cyp3A4, Cyp3A5, Cyp3A7, and Cyp3A43 (cyt3). Cyp3A5 is of particular interest because it is expressed in the kidney; Cyp3A5*1 expresses the wild-type protein while the Cyp3A5*3 allele (A6986G, rs776746) reduces Cyp3A5 protein expression. In a Japanese population, Zhang et al. found that BP was associated with the level of salt intake in Cyp3A5*3/*3, but not CYP3A5*1/*1.37

ENaC Genes

ENac has major roles in Na+ reabsorption in the distal tubule, regulation of extracellular fluid volume and BP.18 Lifton et al. found that T594M mutation of the β-subunit in black people is associated with a greater chance of hypertension compared with individuals without this mutation.38 On the other hand, neural precursor cell expressed developmentally downregulated 4-like (NEDD4L) is an ubiquitin ligase, express in the distal nephron and regulates the expression of the epithelial Na+ channel.39 Some studies reported association between variation in NEDD4Land salt sensitive hypertension.39,40 Dahlberg et al. found that a common polymorphism located in intron 2 (rs4149601, A/G) of the NEDD4L gene was found to be associated with salt sensitive hypertension.39 Manunta et al. found a combination of two common single nucleotide polymorphisms (rs4149601 and rs2288774) located in the NEDD4L gene is associated with salt sensitive hypertension and suggested that carriers of NEDD4L rs4149601 G-allele have higher ENaC expression compared with carriers of A-allele.40

Genes of Sympathetic Nervous System

The sympathetic nervous system is a primary regulator of acute change in BP and increased sympathetic function has reported in salt sensitive hypertension.41 Weber et al. found that salt-sensitive men have increased noradrenergic receptor sensitivity and circulating cortisol levels.42 The genes encoding for β2-adrenergic receptor (ADRβ2) is located on chromosome 10qr and encoded 477 amino acids. Eisenach et al. found that an amino terminal variant in the β2-adreno receptor that encodes glycin instead of argennin (Arg16gly) has been associated with salt sensitive hypertension.43 Pojoga et al. found a Similar association between this polymorphism and BP in normotensive people.44 Svetkey et al. reported that dietary Na+ restriction blunted the increased NO-mediated β2-ADR responsiveness in Gly16 homozygotes observed in a previous study after normal dietary Na+ intake and demonstrated that β2-ADR downregulation might serve to explain the decreased β2-adreno receptor expression on the fibroblasts of salt sensitive individuals compare with salt resistant and normotensive people.45 Another study has been found that the β2-ADR C79G and β2-ADR A46G SNPs were associated with salt sensitive hypertension. Pojoga et al. have reported that greater risk of salt sensitive hypertension is associated with an allele of A46G and the C allele of C79G.44 They compared the dietary change (from low- to high-sodium balance) in mean arterial pressure (MAP) among the 171 hypertensive subjects. Although baseline (low-sodium) BP was similar among genotype groups, MAP differed significantly by genotype, the 46AA and 79CC homozygotes demonstrated the greatest MAP.

β-3 Subunit of G-Protein

The β-adrenoreceptor-G-protein system is essential for function of adenylyl cyclase.46 Bagos et al. have been reported that polymorphism C825T in exon 19 is associated with salt sensitive hypertension.47 The T allele of this polymorphism is associated with higher risk of salt sensitive hypertension. Siffert et al. found that carriers of TT homozygotes and TC heterozygotes have a higher risk of hypertension compare with CC homozygotes.48

Alpha-Adducin

Adducins are a cytoskeletal protein that may regulate the membrane organization of spectrin-actin.49 Manunta et al. found that a mutation (Gly460Trp) in human’s α-adducin was reported to be associated with salt sensitive hypertension.40 Manunta et al. found the association between Gly460Trp allele and hypertension in some population.50 Wang et al. in a recent meta-analysis involving 454 salt sensitive and 366 non-salt sensitive participants concluded that the association between ADD1 Gly460Trp and salt sensitivity is statistically significant in Asian, but not Caucasian populations; the difference may be related to the greater frequency of ADD1 Gly460Trp in Asians than in Caucasians.51 Wang et al. found that the interaction among ADD1 Gly460Trp, ACE DD, and CYP11B2 −344CC may contribute to the BP response to dietary salt.52

Endothelial Nitric Oxide Synthase

Nitric oxide (NO) is a vasodilator that produced from l-arginine by NO synthase. Harsha et al. reported the association between Glu298Asp variant with hypertension.53 Miyaki et al. found that two polymorphisms of NO synthase, T786C and G894T have been associated with essential hypertension.54 Dengel et al. found an association between T786C polymorphism and salt sensitive hypertension.55

Kallikrein-Kinin System

This system has important roles in the kidney to increase renal blood flow.56 Chao et al. found that the Q121E SNP of kallikrein gene was reported to be associated with hypertension.57 Cervenka et al. found that deletion of the bradykininB2 receptor gene in mice produces salt-sensitive hypertension.58

Conclusion

There is evidence that genetic predisposition modulates the BP response to diet. On the other hand, diet and nutrition can mitigate or enhance the effects of genetic predisposition. Increasing our knowledge of this relationship can lead to physiologically individualized treatment and increased understanding of Pathophysiology. Major focuses in clinical research are to develop personalized treatment strategies that are preemptive and to allow persons to be proactive. While we await new studies that allow us to tailor such interventions and treatments, we must not lose sight of the wealth of information already accumulated on the effects of lifestyle modifications on BP. Reduced sodium intake, the DASH diet, weight loss, and exercise have substantial effects in almost all subgroups of the population and should continue to be widely and broadly promoted.
  53 in total

1.  Early onset salt-sensitive hypertension in bradykinin B(2) receptor null mice.

Authors:  L Cervenka; L M Harrison-Bernard; S Dipp; G Primrose; J D Imig; S S El-Dahr
Journal:  Hypertension       Date:  1999-08       Impact factor: 10.190

Review 2.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 3.  Genetic predisposition to salt-sensitivity: a systematic review.

Authors:  Esther Beeks; Alfons G H Kessels; Abraham A Kroon; Melanie M van der Klauw; Peter W de Leeuw
Journal:  J Hypertens       Date:  2004-07       Impact factor: 4.844

4.  A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene.

Authors:  Z Smolenicka; E Bach; A Schaer; S Liechti-Gallati; B M Frey; F J Frey; P Ferrari
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

5.  "Hypertensive emergency": a useful diagnostic category.

Authors:  R B Hickler
Journal:  Am J Public Health       Date:  1988-06       Impact factor: 9.308

6.  Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension.

Authors:  Midori S Yatabe; Junichi Yatabe; Minoru Yoneda; Tsuyoshi Watanabe; Makoto Otsuki; Robin A Felder; Pedro A Jose; Hironobu Sanada
Journal:  Am J Clin Nutr       Date:  2010-05-05       Impact factor: 7.045

7.  Association of the C-344T polymorphism of CYP11B2 gene with essential hypertension in Hani and Yi minorities of China.

Authors:  Wenru Tang; Hongyan Wu; Xuhong Zhou; Baowen Cheng; Yongli Dong; Li He; Haijing Yu; Lin Xu; Jing Lu; Kaiyuan Li; Chunjie Xiao
Journal:  Clin Chim Acta       Date:  2005-08-26       Impact factor: 3.786

Review 8.  Genetic and nongenetic determinants of salt sensitivity and blood pressure.

Authors:  A W Cowley
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

9.  Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial.

Authors:  David W Harsha; Frank M Sacks; Eva Obarzanek; Laura P Svetkey; Pao-Hwa Lin; George A Bray; Mikel Aickin; Paul R Conlin; Edgar R Miller; Lawrence J Appel
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

View more
  12 in total

Review 1.  Personalized Therapy of Hypertension: the Past and the Future.

Authors:  Paolo Manunta; Mara Ferrandi; Daniele Cusi; Patrizia Ferrari; Jan Staessen; Giuseppe Bianchi
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 2.  The adducin saga: pleiotropic genomic targets for precision medicine in human hypertension-vascular, renal, and cognitive diseases.

Authors:  Ezekiel Gonzalez-Fernandez; Letao Fan; Shaoxun Wang; Yedan Liu; Wenjun Gao; Kirby N Thomas; Fan Fan; Richard J Roman
Journal:  Physiol Genomics       Date:  2021-12-03       Impact factor: 3.107

3.  Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.

Authors:  Raymond L Benza; Mardi Gomberg-Maitland; Teresa Demarco; Adaani E Frost; Adam Torbicki; David Langleben; Tomas Pulido; Priscilla Correa-Jaque; Michael J Passineau; Howard W Wiener; Mayumi Tamari; Tomomitsu Hirota; Michiaki Kubo; Hemant K Tiwari
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

4.  Ethnic disparities among food sources of energy and nutrients of public health concern and nutrients to limit in adults in the United States: NHANES 2003-2006.

Authors:  Carol E O'Neil; Theresa A Nicklas; Debra R Keast; Victor L Fulgoni
Journal:  Food Nutr Res       Date:  2014-11-18       Impact factor: 3.894

Review 5.  Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension.

Authors:  Kaustav Majumder; Jianping Wu
Journal:  Int J Mol Sci       Date:  2014-12-24       Impact factor: 5.923

Review 6.  Macronutrients and the FTO gene expression in hypothalamus; a systematic review of experimental studies.

Authors:  Saeid Doaei; Naser Kalantari; Nastaran Keshavarz Mohammadi; Ghasem Azizi Tabesh; Maryam Gholamalizadeh
Journal:  Indian Heart J       Date:  2017-01-24

7.  Some dietary factors can modulate the effect of the zinc transporters 8 polymorphism on the risk of metabolic syndrome.

Authors:  Firoozeh Hosseini-Esfahani; Parvin Mirmiran; Gelareh Koochakpoor; Maryam S Daneshpour; Kamran Guity; Fereidoun Azizi
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

Review 8.  Review of studies on the fat mass and obesity-associated (FTO) gene interactions with environmental factors affecting on obesity and its impact on lifestyle interventions.

Authors:  Naser Kalantari; Saeid Doaei; Nastaran Keshavarz-Mohammadi; Maryam Gholamalizadeh; Naeimeh Pazan
Journal:  ARYA Atheroscler       Date:  2016-11

9.  Examining the Potential Effect of a Salt Sensitivity Biomarker in Korean American Immigrants: A Pilot Study.

Authors:  Jisook Ko; Moonju Lee; Darpan I Patel; Vivian Nguyen; Jing Wang
Journal:  J Immigr Minor Health       Date:  2021-07-31

10.  Modeling health gains and cost savings for ten dietary salt reduction targets.

Authors:  Nick Wilson; Nhung Nghiem; Helen Eyles; Cliona Ni Mhurchu; Emma Shields; Linda J Cobiac; Christine L Cleghorn; Tony Blakely
Journal:  Nutr J       Date:  2016-04-26       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.